medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2013, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2013; 11 (2)

Perhydrosqualene and CLG-PVP in the treatment of wrinkles, volume defects and fine lines

Escobar FSA, Rodríguez RXC

Language: Spanish
References: 44
Page: 104-111
PDF size: 417.03 Kb.


ABSTRACT

Temporary bioimplants used for correcting facial defects must be inert, easily manipulated, durable and immunologically well tolerated to ensure safe and effective results. This study evaluates both the effectiveness and biosafety of a new collagen- PVP-perhydrosqualene combination during a follow-up period of 6 months to assess the intensity of dermal response and aesthetic results


REFERENCES

  1. Rubin JP, Yaremchuk MJ. “Complications and toxicities of implantable biomaterials used in facial reconstructive and aesthetic surgery: A comprehensive review of the literature”. Plast Reconstr Surg 1997; 100: 1336-1353.

  2. Rossmussen JE. “Microlipoinjection: Autologus Fat Grafting”. Arch Dermatol 1988; 124: 1340-1343.

  3. Sheldon VP. “Silicone, Fibrel and Collagen Implantation for Facial Lines and Wrinkles”. J Dermatonl Surg Oncol 1990; 16: 957-961.

  4. Millikan Larry et al. “A multicenter study. Treatment of depressed cutaneous scars with gelatin matrix implant”. J Am Acad Dermatol 1987; 16: 1155-1162.

  5. Olienius M. “The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles and folds”. Aesthetic Plastic Surgery 1998; 22: 97-101.

  6. Collagen Biomedical Ibérica. Division do collagen corporation: Implantes de colágeno Zyderm y Zyplast: manual medico, 1999.

  7. Tromavitch T, Stegman S, Glogau R. “Zyderm collagen: Implantation technics”. J Am Acad Dermatol 1984; 10: 273-278.

  8. Eppley BL, Summerlin DJ, Sadove AM. “A potential biomaterial composite for dermal and subcutaneous augmentantion”. Ann Plast Surg 1994; 32(5): 463-468.

  9. Ersek RA, Beisang AA. “Bioplastique: A new textured copolymer microparticle promises permanence in soft tissue augmentantion”. Southwest Texas State University and University of Minnesota, Departments of Plastic and Reconstructive Surgery, 1990.

  10. Salgado CRM. Incremento del grosor cutáneo por la administración de bioimplantes en un modelo murino: Estudio clínico e histológico. Universidad La Salle, Escuela de Química, 2000.

  11. Krötzsch-Gomez FE. “Efecto del Fibroquel© sobre el metabolismo de la colágeno en cultivos celulares de fibroblastos y macrófagos de ratas”. Tesis de maestría, 1995.

  12. Krötzsch-Gomez FE. “Análisis del efecto de la colágeno-polivinilpirrolidona sobre la expresión in vitro de algunos mediadores solubles que participan en el metabolismo de la colágeno”. Tesis de doctorado, 1999.

  13. Krötzsch-Gomez FE, Furuzawa-Carballeda J, Reyes-Márquez R, Quiróz- Hernández E, Díaz de León L. “Cytokine is down-regulated by collagen- polyvinilpiridone in hypertrophic scars”. J Invest Dermatol 1998; 111: 828-834.

  14. Flesh P. “The cementing substance of the human homy layer”. J Soc Cos Chem 1962; XIII(3):113.

  15. Squalane 1980. Expert Panel Evaluation.

  16. U.S. Food & Drug Administration. Fecha de publicación: mayo de 2001.

  17. Furuzawa-Carballeda J, Rojas E, Valverde M, Castillo I, Díaz de León L, Krotzsch E. “Cellular and humoral responses to collagen-polyvinylinvestigaciones pyrrolidone administered during short and long periods in humans”. Can J Physiol Pharmacol 2003; 81: 1029-1035.

  18. Coleman SR. “Structural fat grafts: the ideal filler?” Clin Plast Surg. 2001; 28:111-119.

  19. Bastard JP, Cuevas J, Cohen S, Jardel C, et al. “Percutaneous adipose tissue biopsy by mini-liposuction for metabolic studies”. J Parenteral Enteral Nutr 1994; 18: 466-468.

  20. Furuzawa-Carballeda J, Cabral AR, Zapata-Zuñiga M, Alcocer-Valera J. “Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial”. The Journal of Rheumatology 2003; 30: 256-259.

  21. Chimal-Monroy J, Bravo-Ruíz T, Krötzsch-Gómez FE, Díaz de León L. “Implantes de fibroquel aceleran la formación de hueso nuevo en defectos óseos inducidos experimentalmente en cráneos de rata: un estudio histológico”. Rev Biomed (1997); 8: 81-88.

  22. Monrreal J. “Injertos de grasa autóloga”. Cirugía Plástica Iberoamericana 2005; 31(2): 137-146.

  23. Coleman SR. “Facial recontouring with lipostructure”. Clin Plast Surg 1997; 24: 347-367.

  24. Cervantes-Sánchez CR, Olaya E, Testas M, García-López N, Coste G, Arrellin G, Luna A, Krötzsch FE. “Collagen-PVP, a collagen synthesis modulator, decreases intraperitoneal adhesions”. J Sur Res 2003; 110: 207-210.

  25. Furuzawa-Carballeda J, Rodrígez-Calderón R, Díaz de León L, Alcocer- Varela J. “Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen”. Clin Exp Immunol 2002; 130: 140-149.

  26. “Final Report on the Safety Assessment of Squalane and Squalene”. Int J of Toxicology 1982; 1: 37. DOI: 10.3109/10915818209013146.

  27. Chimal-Monroy J, Bravo-Ruíz T, Furosawa-Carballeda J, Lira JM, De la Cruz JC, Almazán A, Krötzsch-Gómez FE, Arrellin G, Díaz de León L. “Colallen-PVP accelerates new bone formation of experimentally induced bone defects in rat Skull and promotes the expression of osteopontin and SPARC during bone repair of rat femoral fractures”. Ann NY Acad Sci 1998; 857: 232-236.

  28. Krötzsch-Gomez FE, Furuzawa-Carballeda J, Reyes-Márquez R, Quiroz- Hernández E, Díaz de León L. “Cytokine expression is down-regulated by collagen-polyvinylpirolidone in hipertrophic scars”. J Invest Dermatol 1998; 111: 828-834.

  29. Bekturov EA, Bakauova ZKh. Synthetic Water-Soluble Polymes in Solution. Basilea, Huethig & Wepf, 1986.

  30. Abuin E, Lissi E, Gargallo L, Radic D. Macromoléculas en solución. Santiago de Chile; PNUD-UNESCO, 1987.

  31. Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, et al. “Juvederm vs Zyplast Nasolabial Fold Study Group. Comparison of smooth gel hyaluronic acid dermal fillers with crosslinked bovine collagen: a multicenter, double.masked, randomized, within- subjet study”. Dermatol Surg 2007; 33 (Suppl 2): S128-135.

  32. Yoshiko M, et al. “Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo”. Nucleic Acids Res 2004; 32(13): e109. Published online 2004 July 22. doi: 10.1093/nar/gnh093.

  33. Matarasso SL. “Injectable collagens: lost but not forgotten-a review of products, indications, complications, and injection techniques”. Plast Reconstr Surg 2007; 120 (Suppl): 17-26.

  34. Sergott TJ, Limoli JP, Baldwin CM, Laub DR. “Human adjuvant disease, possible autoimmune disease after silicone implantation : A review of the literature, case studies, and speculation for the future”. Plast Reconstr Surg 1986; 78: 104-114.

  35. Habal MB, Powell ML, Schimpff RD. “Immunological evaluation of the tumorigenic response to implanted polymers”. J Biomed Mater Res 1980; 14(4): 455-466.

  36. Ellenbogen R, Rubin L. “La terapia líquida inyectable de la silicona: la morbosidad y la mortalidad Humanas”. Journal of the American Medical Association 1975; 234, 309-309.

  37. Millard DR, Maisels DD. “Silicone granuloma of the skin and subcutaneous tissue”. Am J Surg 1966; 112-119.

  38. Bigata X, Ribera M, Bielsa I, Ferrandiz C. “Adverse granulomatous reaction after cosmetic dermal silicone injection”. Dermatol Surg 2001; 27(2): 198-200.

  39. Kopf EH, Vinnik CA, Bongiovi JJ, Dombrowski DJ. “Complications of silicone injections”. Rocky Mountain Medical Journal 1976; 75: 77-80.

  40. PLM, ed. 57, México, 2011, 1396-1397.

  41. Coleman SR. “Facial recontouring with lipostructure”. Clin Plast Surg 1997; 24: 347-367.

  42. Amin Y, Barakat AY. Renal Disease. Clinical Evaluation and Diagnosis. Nueva York, Springer-Verlag, 1989.

  43. Barrat MT. Pediatric Nephrology. 4a ed., Baltimore: Lippincott Williams & Wilkins, 1999.

  44. Ravel R. Clinical Laboratory Medicine. 6a ed., St. Louis: Mosby-Year Book, 1995.




2020     |     www.medigraphic.com